Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer

Technology appraisal guidance
Reference number: TA192
Published: 28 July 2010

Lung cancer (non-small-cell, first line) - gefitinib: appendix b - proposal paper presented to the Institute's Guidance Executive

Lung cancer (non-small-cell, first line) - gefitinib: appendix b - proposal paper presented to the Institute's Guidance Executive

Lung cancer (non-small-cell, first line) - gefitinib: appendix b - proposal paper presented to the Institute's Guidance Executive
13 October 2014
(365.47 Kb 46 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 10 October 2014